Raras
Buscar doenças, sintomas, genes...
Síndrome de perturbação do desenvolvimento-sobrecrescimento-dismorfia facial-perturbação comportamental
ORPHA:652487CID-10 · Q87.3OMIM 620439DOENÇA RARA

É uma doença genética autossômica dominante que causa deficiência intelectual, caracterizada por atraso no desenvolvimento, atraso predominante na fala, características de autismo ou de Transtorno de Déficit de Atenção e Hiperatividade (TDAH), ser amigável demais, músculos mais flácidos em todo o corpo (hipotonia generalizada), sobrepeso ou obesidade, e características físicas diferentes (dismórficas).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É uma doença genética autossômica dominante que causa deficiência intelectual, caracterizada por atraso no desenvolvimento, atraso predominante na fala, características de autismo ou de Transtorno de Déficit de Atenção e Hiperatividade (TDAH), ser amigável demais, músculos mais flácidos em todo o corpo (hipotonia generalizada), sobrepeso ou obesidade, e características físicas diferentes (dismórficas).

🏥
SUS: Cobertura parcialScore: 40%
Triagem neonatal (Fase 5)Centros em: PA, PE, CE, DF, SP +5CID-10: Q87.3
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
8 sintomas
😀
Face
4 sintomas
📏
Crescimento
3 sintomas
👂
Ouvidos
3 sintomas
👁️
Olhos
2 sintomas
🦴
Ossos e articulações
2 sintomas

+ 12 sintomas em outras categorias

Características mais comuns

100%prev.
Atraso global do desenvolvimento
Frequência: 22/22
84%prev.
Atraso no desenvolvimento da fala e da linguagem
Frequência: 16/19
80%prev.
Deficiência intelectual, leve
Frequência: 16/20
45%prev.
Olho profundamente inserido
Frequência: 10/22
41%prev.
Nariz bulboso
Frequência: 9/22
41%prev.
Comportamento autista
Frequência: 9/22
35sintomas
Muito frequente (3)
Frequente (7)
Ocasional (23)
Sem dados (2)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 35 características clínicas mais associadas, ordenadas por frequência.

Atraso global do desenvolvimentoGlobal developmental delay
Frequência: 22/22100%
Atraso no desenvolvimento da fala e da linguagemDelayed speech and language development
Frequência: 16/1984%
Deficiência intelectual, leveIntellectual disability, mild
Frequência: 16/2080%
Olho profundamente inseridoDeeply set eye
Frequência: 10/2245%
Nariz bulbosoBulbous nose
Frequência: 9/2241%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1
Últimos 10 anos200publicações
Pico2026175 papers
Linha do tempo
2025Hoje · 2026
Publicações por ano (últimos 10 anos)

Triagem neonatal (Teste do Pezinho)

👶
Teste: qPCR para deleção de SMN1 em sangue seco
Fase 5 do PNTNpending
Incidência no Brasil: 1:10.000

A triagem neonatal permite diagnóstico precoce e início imediato do tratamento.

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição.

Autosomal dominant
SRRM2Serine/arginine repetitive matrix protein 2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable)

LOCALIZAÇÃO

NucleusNucleus speckle

VIAS BIOLÓGICAS (3)
mRNA Splicing - Major PathwayDengue Virus-Host InteractionsmRNA Polyadenylation
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal dominant 72

An autosomal dominant disorder characterized by mild developmental delay and intellectual disability, predominant speech delay, autistic or attention deficit-hyperactivity disorder features, overfriendliness, generalized hypotonia, overweight, and dysmorphic facial features.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
606.8 TPM
Útero
566.9 TPM
Fallopian Tube
562.0 TPM
Cervix Ectocervix
531.2 TPM
Nervo tibial
521.3 TPM
OUTRAS DOENÇAS (1)
intellectual developmental disorder, autosomal dominant 72
HGNC:16639UniProt:Q9UQ35

Variantes genéticas (ClinVar)

232 variantes patogênicas registradas no ClinVar.

🧬 SRRM2: NM_016333.4(SRRM2):c.3215dup (p.Ser1073fs) ()
🧬 SRRM2: NM_016333.4(SRRM2):c.7955C>G (p.Ala2652Gly) ()
🧬 SRRM2: NM_016333.4(SRRM2):c.4857T>A (p.Asp1619Glu) ()
🧬 SRRM2: NM_016333.4(SRRM2):c.1163A>G (p.Gln388Arg) ()
🧬 SRRM2: NM_016333.4(SRRM2):c.1001_1008dup (p.Asp337fs) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

3 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de perturbação do desenvolvimento-sobrecrescimento-dismorfia facial-perturbação comportamental

Centros de Referência SUS

13 centros habilitados pelo SUS para Síndrome de perturbação do desenvolvimento-sobrecrescimento-dismorfia facial-perturbação comportamental

Centros para Síndrome de perturbação do desenvolvimento-sobrecrescimento-dismorfia facial-perturbação comportamental

Detalhes dos centros

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Tau pathology in epilepsy: emerging mechanisms and translational opportunities.

Brain : a journal of neurology2026 Mar 23

The onset of epilepsy in adulthood occurs most commonly after 55 years of age. Given the ageing global population, this disorder represents an increasing burden on healthcare and society. The bidirectional link between epilepsy and dementia is a focus of intense research with underlying tau pathology highlighted as a potential mechanistic link. In this review, we examine the evidence for tau-related neurodegenerative processes in epilepsy beginning with how changes in biochemical and structural properties of the tau protein can lead to abnormal phosphorylation and pathological aggregation. We consider the role of tau in seizure occurrence and cognitive difficulties in experimental animal epilepsy models to human epileptic syndromes. Seizure prevalence is evaluated across established primary and secondary tauopathies to understand the associated hyperexcitability phenotype. We discuss the use of neurophysiology, metabolic imaging and novel fluid biomarkers as non-invasive measures of potential underlying neurodegeneration in epilepsy. It may, for example, be that these can be combined with remote measures of cognition and other physiological parameters to provide accurate longitudinal monitoring of cognition and underlying pathology. We also explore clinical trials that have targeted pathological tau accumulation in neurodegenerative conditions and consider an ongoing clinical study with sodium selenate, an enhancer of protein phosphatase enzyme PP2A, in people with epilepsy. These efforts signify a novel disease-modifying era with treatments that reduce seizures and modify cognitive outcomes in people with epilepsy. Our analysis of the literature underscores the need for more in-depth characterization of tau pathology, at biochemical and structural levels, in brain tissue and peripheral samples from people with epilepsy as an important step to deciphering the role of tau in the pathogenesis of epilepsy and related disorders. Examining the relationships between tau pathology and cognitive impairment in those with epilepsy provides critical perspectives on a potential causal tau pathomechanism that may have important roles in epileptogenesis and dementia.

#2

Novel PCDH12 pathogenic missense variants cause neurodevelopmental disorders with ocular malformation.

medRxiv : the preprint server for health sciences2026 Mar 06

Protocadherin-12 (PCDH12), a cell-adhesion protein belonging to the non-clustered protocadherin family, plays a crucial role in the establishment and regulation of neuronal connections and communication. Bi-allelic loss-of-function (LoF) variants in the PCDH12 gene have been associated with several neurodevelopmental disorders (NDDs) such as diencephalic-mesencephalic junction dysplasia syndrome, cerebral palsy, and cerebellar ataxia, often accompanied by ocular abnormalities. However, genotypes exhibit variable expressivity. Affected individuals sharing the same PCDH12 variant presenting differing phenotypic severities have posed major challenges towards identification of the underlying pathogenic mechanisms. Here, we report three affected individuals from two families, each harbouring non-truncating pathogenic missense variants in PCDH12 . The patients are compound heterozygous, with each individual carrying one extracellular [c.1742T>G (p.Val581Gly) and c.1861_2del/insCA (p.Ile621His)] and one intracellular variant [c.3370C>T (p.Arg1124Cys) and c.3445G>A (p.Asp1149Asn] on each allele. The children present with a range of phenotypes similar to those associated with LoF variants. One child exhibited microcephaly and seizures, while the two siblings displayed developmental delays and severe behavioral disorders. All three children experienced some degree of visual impairment. The missense variants provided new insights into the neurodevelopmental consequences of compromised PCDH12 function by distinguishing the specific consequences associated with dysfunction in the extracellular versus intracellular domains of PCDH12. All identified missense variants are predicted to be deleterious and destabilizing. The expression of PCDH12 in HEK293T and HeLa cells demonstrated that PCDH12 is expressed effectively, regardless of the presence of missense variants. However, the extracellular variants p.Val581Gly and p.Ile621His compromised the stability of PCDH12's homophilic adhesion. Additionally, we found evidence of an interaction between PCDH12 and the extracellular domain of the epilepsy-associated PCDH19 protein. PCDH12 extracellular missense variants also affect PCDH19 stability. Our study provides evidence that PCDH12 mediates both homophilic and heterophilic interactions. Our findings also highlight the importance of stable PCDH12-mediated adhesion, emphasizing the need to further study the functional consequences of PCDH12 missense variants on brain and visual system development.

#3

Characterizing SCN1A -Related Disorders Using Real-World Data Across 681 Patient-Years.

medRxiv : the preprint server for health sciences2026 Mar 02

SCN1A -related disorders are the single most common monogenic cause of epilepsy and represent a major focus of precision medicine efforts. In conjunction with existing prospective studies, the analysis of real-world data obtained during routine clinical care can expand upon the scale and duration of available data and contribute to the development of meaningful outcomes for clinical trials. Here, we leveraged real-world data to delineate the longitudinal disease history of 100 individuals with SCN1A -related disorders using a systematic approach. We mapped a total of 671 unique clinical terms to a standardized framework in monthly increments across 681 patient-years, including 75 terms related to seizure types. Within this cohort, 89 individuals had presumed loss-of-function variants in SCN1A based on variant type and clinical diagnosis, including those with Dravet syndrome ( N = 79) and genetic epilepsy with febrile seizures plus ( N = 10). Ten individuals had a non-Dravet developmental and epileptic encephalopathy caused by gain-of-function variants in SCN1A . By annotating seizure type and frequency in monthly time-bins, we assessed seizure burden. A median of 17 changes in seizure frequency and ten terms referring to seizure type were identified per participant. Myoclonic seizures occurred with high frequency (median >5 daily), whereas hemiclonic, focal impaired consciousness, and bilateral tonic-clonic seizures occurred more rarely (median monthly). Retrospective analysis of developmental histories showed a range of cognitive abilities. Neurodevelopmental differences were observed in 83% (83/100) of individuals, of whom 83% (69/83) demonstrated delayed language skills. Motor coordination impairments, including gait disturbance, ataxia, hypotonia, and imbalance were annotated in 69% (69/100) of participants. EEG findings varied with age; most were reported as normal before nine months of age, after which the prevalence of abnormal interictal findings increased. Individuals with different clinical syndromes had unique medication landscapes, with 554 prescriptions of 37 unique therapies. Changes in treatment coincided with the diagnosis of an SCN1A -related disorder, with an increase in cannabidiol, clobazam, and fenfluramine and reduction in sodium channel-blocker use following genetic diagnosis. In summary, we reconstructed the longitudinal disease history of SCN1A -related disorders from electronic medical records using a standardized framework for the analysis of real-world clinical data. We refine existing natural history data of SCN1A -related disorders by providing a granular landscape of seizures, comorbidities, and treatment approaches over time.

#4

Recessive Loss of DIAPH1 Function Causes a Progressive Neurodevelopmental Syndrome with Variable Immunological Involvement.

Genetics in medicine : official journal of the American College of Medical Genetics2026 Mar 16

Biallelic DIAPH1 pathogenic variants cause a neurodevelopmental syndrome occasionally associated with immunodeficiency. This study aims to define the clinical and immunological spectrum of DIAPH1-related neuroimmunological syndrome and explore the gene's developmental role using vertebrate models. 53 individuals with biallelic DIAPH1 variants, including 33 previously unreported patients were studied. Clinical features were analysed and functional studies were conducted using knockout models in Danio rerio and Xenopus tropicalis. Clinical features included developmental delay, intellectual disability, progressive microcephaly, cortical visual impairment or blindness, epilepsy, and frequent occipital-predominant brain abnormalities. Almost half suffered from infections, mainly affecting their respiratory tract related to epilepsy and aspiration. Although the majority had normal lymphocyte subsets and serum immunoglobulins, T-cell receptor excision circles and naïve T-lymphocyte counts were consistently low. The Xenopus model mirrored growth and eye defects seen in humans, while zebrafish exhibited no overt malformations but showed seizure-like behaviour in Phenothiazine assays. DIAPH1 is critical for neurodevelopment, immune regulation, and DNA repair. The DNA repair defect may influence susceptibility to infection, lymphoma, or treatment-related toxicity. Although absolute T-cell numbers are not consistent with SCID, impaired T-cell maturation suggests these patients could be identified by TREC newborn screening before neurological symptoms develop.

#5

Disturbed mitochondrial maturation in cardiolipin remodeling-deficient cardiomyocytes.

iScience2026 Mar 20

Barth syndrome, a rare X-linked genetic disorder, features early-onset cardiomyopathy. The causal gene, TAFAZZIN, encodes a transacylase that mediates the acyl chain remodeling of cardiolipin, a critical phospholipid in the inner mitochondrial membrane. While Barth syndrome exhibits hallmark cardiolipin abnormalities, the precise mechanisms linking TAFAZZIN deficiency and disturbed cardiolipin metabolism to progressive cardiac dysfunction remain unclear. In this study, we modeled Barth syndrome cardiomyopathy in human induced pluripotent stem cell-derived cardiomyocytes with in vitro maturation treatments that simulate heart developmental stimuli. We found that cardiomyocyte maturation involves progressive cristae dynamics associated with protein and lipid alterations in the inner mitochondrial membrane. TAFAZZIN-deficient cardiomyocytes fail to adapt to the developmental stimuli, resulting in damaged cristae, compromised mitochondrial respiration, and cardiomyocyte dysfunction. These results demonstrate that TAFAZZIN deficiency perturbs functional and structural development of mitochondria, which may contribute to mitochondrial dysfunction and associated childhood progression to cardiomyopathy in Barth syndrome.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 200

2026

The selective 5-HT1A receptor biased agonist, NLX-101, corrects anomalous behavioral phenotype in a mouse model of fragile X syndrome.

Progress in neuro-psychopharmacology & biological psychiatry
2026

Clinical and genetic basis of congenital gonadotropin deficiency.

Human reproduction open
2026

Tau pathology in epilepsy: emerging mechanisms and translational opportunities.

Brain : a journal of neurology
2026

Update on Congenital Cranial Dysinnervation Disorders (CCDDs).

International ophthalmology clinics
2026

Novel PCDH12 pathogenic missense variants cause neurodevelopmental disorders with ocular malformation.

medRxiv : the preprint server for health sciences
2026

Characterizing SCN1A -Related Disorders Using Real-World Data Across 681 Patient-Years.

medRxiv : the preprint server for health sciences
2026

Recessive Loss of DIAPH1 Function Causes a Progressive Neurodevelopmental Syndrome with Variable Immunological Involvement.

Genetics in medicine : official journal of the American College of Medical Genetics
2026

Established and emerging non-cellular therapies in inherited bone marrow failure syndromes.

Frontiers in immunology
2026

Disturbed mitochondrial maturation in cardiolipin remodeling-deficient cardiomyocytes.

iScience
2025

Clinical and molecular findings in Cornelia de Lange syndrome. Case series.

Andes pediatrica : revista Chilena de pediatria
2026

Strengthening Undergraduate Medical Education for Inclusive Health Care for People With Down Syndrome and Intellectual and Developmental Disabilities in Medical Schools: Protocol for a Scoping Review.

JMIR research protocols
2026

Identification of autosomal and sex chromosome aneuploidies using next generation sequencing.

Bioinformatics (Oxford, England)
2026

Case Report: Compound heterozygous mutations in the IDUA gene causing mucopolysaccharidosis type I with uterine developmental abnormality.

Frontiers in pediatrics
2026

A Novel Phenotypic Presentation of Absence Seizures in a 15-Month-Old with PIGK-Related GPI Biosynthesis Disorder: A Case Report.

Case reports in neurology
2026

The 9th International RASopathies Symposium.

American journal of medical genetics. Part A
2026

A novel KDM6A c.2429dup mutation causing kabuki syndrome type 2 identified in a fetus with increased nuchal translucency.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
2026

Clinical-genetic features of the TBCE-related spectrum disorders: A focus on the childhood-onset neurodegenerative phenotype.

Molecular genetics and metabolism
2026

Rare and emerging arterial diseases of the supra-aortic trunks: Diagnostic and therapeutic insights.

Vascular diseases (Paris, France)
2026

Deubiquitinase USP8 regulates the spindle assembly checkpoint in oocytes.

Science advances
2026

Ultra-rare biallelic THAP12 variants cause loss of function and underlie severe epileptic encephalopathy.

medRxiv : the preprint server for health sciences
2026

The Management of Evolving Neuropsychiatric Symptoms in a Female with Fragile X Syndrome: A Case Report.

Psychopharmacology bulletin
2026

Protocol for an open-label, randomised, controlled trial to evaluate the efficacy and safety of sotatercept add-on therapy compared with pulmonary vasodilator-based standard of care for pulmonary vasodilator-resistant pulmonary arterial hypertension associated with unrepaired congenital shunts (atrial septal defect, ventricular septal defect or patent ductus arteriosus), including Eisenmenger syndrome: the SuMILE trial.

BMJ open
2026

Right ureterovesical junction cyst associated with ipsilateral renal agenesis: a case report of a possible Wolffian duct maldevelopment.

Frontiers in medicine
2025

[Analysis of clinical features and genetic variants in a Chinese pedigree affected with Spondyloepiphyseal dysplasia type Ehlers-Danlos syndrome due to variants of B3GALT6 gene].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

A novel heterozygous pathogenic variation in the MECP2 gene causing typical Rett syndrome: a case report.

Translational pediatrics
2026

Identification of an emerging heterozygous variant in KAT6A by whole exome sequencing: a case report.

Translational pediatrics
2026

Novel ANKRD11 Mutation in KBG Syndrome: A diagnostic triad of hearing loss, radiological macrodontia and artificial intelligence-assisted facial phenotyping.

Sultan Qaboos University medical journal
2026

Congenital Ocular Motor Apraxia as the First Sign of Joubert Syndrome: A Case Report.

Cureus
2026

De Novo 3q27.1 Microdeletion Refines the Critical Region and Implicates PSMD2 Haploinsufficiency in Growth and Neurodevelopmental Abnormalities.

American journal of medical genetics. Part A
2026

Congenital Symptomatic Scaphoid-Trapezium Coalition in a Pediatric Patient With VACTERL Association.

Journal of hand surgery global online
2026

Early Childhood-Onset Prosopometamorphopsia Following Respiratory Tract Infection With Serological Evidence of Mycoplasma pneumoniae Exposure: A Pediatric Case Report.

Cureus
2026

Expanding the Coffin-Siris syndrome spectrum: genetic, dysmorphic, and endocrine findings in eight cases.

European journal of pediatrics
2026

Evaluating the Diagnostic Yield of Prenatal Trio Exome Sequencing in Families With a History of Developmental Delay and Intellectual Disability.

American journal of medical genetics. Part A
2026

Organ-Specific Histopathological Effects of Prenatal Alcohol Exposure: A Narrative Review.

Congenital anomalies
2026

Community Based Pre-School Screening to Detect Developmental, Behavioural, Hearing and Vision Problems in Survivors of Neonatal Cardiac Surgery.

Journal of paediatrics and child health
2026

Child Neurology: Multiple Genetic Etiologies Causing Dandy-Walker Variant With Microcephaly, Epilepsy, and Global Developmental Delay.

Neurology
2026

Genetic analysis of triplicated genes affecting sex-specific skeletal deficits in Down syndrome model mice.

G3 (Bethesda, Md.)
2026

Navigating challenges: a child with Apert syndrome and global developmental delay from a low-income family.

BMJ case reports
2026

Context-dependent effects of adaptive immunity on IFN-α-mediated neurotoxicity in Aicardi-Goutières syndrome.

Neurobiology of disease
2026

Analysis of treatment outcome variations in infantile epileptic spasms syndrome.

Frontiers in neurology
2026

Etiological Analysis and Classification of 108 Patients with Infantile Epileptic Spasms Syndrome Based on the 2017 International League Against Epilepsy Classification.

Noro psikiyatri arsivi
2026

Animal models of hypoplastic left heart syndrome: genetic and anatomical approaches.

Pediatric research
2026

Collectin-11 regulates osteoclastogenesis and bone maintenance via a complement-dependent mechanism.

Proceedings of the National Academy of Sciences of the United States of America
2026

Mutation type-specific transcriptomic signatures and readthrough therapy rescue in SMC1A-related developmental and epileptic encephalopathy.

Epilepsia
2026

Comparative Evaluation of Sella Turcica Morphology and Dimensions in Skeletal Class III Malocclusion and Cleft Lip and Palate Patients Versus Class I Individuals.

Clinical and experimental dental research
2026

Elevated gamma spectral event peak power during auditory chirp is associated with neuropsychiatric features in Fragile X syndrome.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
2026

Cell-type-specific alternative splicing in the brain and kidney of a Setbp1S858R Schinzel-Giedion syndrome mouse.

Disease models & mechanisms
2026

Macrodystrophia Lipomatosa: A Rare Case of Right Lower Extremity Gigantism Associated With Syndactyly.

Clinical case reports
2026

Congenital Temporomandibular Joint Ankylosis: Investigating Potential Genetic Etiologies with Whole Exome Sequencing.

Journal of clinical medicine
2026

Sleep-Disordered Breathing in Chung-Jansen Syndrome.

International journal of molecular sciences
2026

Xp22.33 Duplication Encompassing PAR1 in a Male with Syndromic Neurodevelopmental Disorder and Tall Stature.

Genes
2026

Foundations of an Ovine Model of Fragile X Syndrome.

Genes
2026

A Splice Acceptor Variant in DLL3 Is Associated with Spondylocostal Dysostosis in a Litter of Mixed-Breed Dogs.

Genes
2026

A Clinical Practice Example of Smith-Magenis Syndrome in the Neuropediatric Clinic: Etiology, Clinical Presentation, Diagnostics and Therapeutic Approaches-A Case Report.

Children (Basel, Switzerland)
2026

Orofacial clefting in PHF6-related Börjeson-Forssman-Lehmann syndrome.

BMJ case reports
2026

Fenfluramine in SCN1A-related GEFS+: A multicenter observational study on efficacy, EEG improvement, and tolerability.

Epilepsia open
2026

Congenital core myopathy linked to SOX5: Expanding the phenotypical spectrum of Lamb-Shaffer syndrome.

Journal of neuromuscular diseases
2026

Cardiac conduction system malformations in heterotaxy result from dysregulated Pitx2 expression.

JCI insight
2026

Case Report: A female case of X-linked intellectual disability syndrome type 34 caused by a NONO frameshift variant and literature review.

Frontiers in pediatrics
2026

Input-and cell-type-specific developmental alterations to thalamic synapses in a Dravet syndrome mouse model.

bioRxiv : the preprint server for biology
2026

Multi-omics investigation of thyroid development and dysfunction in down syndrome.

Human molecular genetics
2026

Novel Mutations in KCNJ10 Gene Associated With SeSAME Syndrome: Rare Disorder With Possible Common Mutation.

Molecular genetics & genomic medicine
2026

Use of fenfluramine in MECP2-related Rett syndrome: Findings from a retrospective multicenter pediatric case series.

Epilepsy & behavior : E&B
2026

Bi-allelic variants in FSD1L cause a neurodevelopmental disorder overlapping with L1 syndrome.

American journal of human genetics
2026

Myosin VB is critical for progenitor cell identity and function in the intestine.

Stem cell reports
2026

The microcephaly-associated protein YIPF5 differentially regulates ER export.

iScience
2026

In vivo base editing of Chd3 rescues behavioural abnormalities in mice.

Nature
2026

Communicative Development Inventories (CDIs) in etiologically diverse developmental conditions: A systematic review.

Research in developmental disabilities
2026

NONO-Related Syndromic X-Linked Developmental Disability 34: Further Clinical and Molecular Delineation in a Prenatal Cohort.

Prenatal diagnosis
2026

Analysis of intracellular organelles in neurons differentiated from iPSCs of Chédiak-Higashi syndrome patients.

Pediatrics international : official journal of the Japan Pediatric Society
2026

Fetal Rapid Eye Movement Sleep Dysfunction as a Potential Early Indicator for NALCN-Related CLIFAHDD Syndrome: A Case Report.

Prenatal diagnosis
2026

Börjeson-Forssman-Lehmann Syndrome in a Pediatric Patient: A Four-Year Longitudinal Case Report Focused on Functional Evolution and Rehabilitation.

Cureus
2025

Case Report: Nephrocalcinosis from pancreatic hypoplasia in HNF1B disease: a multigenerational expression with genetic confirmation in the youngest generation.

Frontiers in medicine
2026

A novel NMD-escaping STAG2 variant associated with syndromic neurodevelopmental delay, growth failure, and distinctive dysmorphism: expanding the phenotype in male patients and literature review.

Gene
2026

Differential disruption of gonadal development by DEHP and paracetamol in male and female Wistar rats.

Reproductive toxicology (Elmsford, N.Y.)
2026

Comprehensive analysis of copy number variations in congenital heart defects Tunisian patients: chromosomal microarray analysis insights.

Molecular cytogenetics
2026

Role of SPAG6 in regulating physiological functions and tumorigenesis (Review).

International journal of oncology
2026

Clinical Presentation, Genetics, and Laboratory Testing with Integrated Genetic Analysis of Molecular Mechanisms in Prader-Willi and Angelman Syndromes: A Review.

International journal of molecular sciences
2026

Hydrogel-imposed boundary conditions guide single-lumen neuroepithelial morphogenesis.

bioRxiv : the preprint server for biology
2026

Protective role of early Tnfsf15 upregulation in limiting glomerular injury and proteinuria in experimental Alport Syndrome.

Journal of pharmacological sciences
2026

WAS Protein Deficiency Disrupts Memory B Cell Formation During Acute LCMV Infection.

Journal of clinical immunology
2026

Four women whose pioneering contributions to science have been largely overlooked.

eLife
2025

Expanding the Clinical Spectrum of RERE-Related Disorders: A Case Report of Neurodevelopmental Disorder with Brain Malformations Including Chiari Type I.

Molecular syndromology
2026

Nager Syndrome Revisited: Integrating In Vivo and In Vitro Models to Decipher SF3B4-Dependent Tissue Coordination.

WIREs mechanisms of disease
2026

A human electrophysiological signature of Fragile X pathophysiology is shared in V1 of Fmr1-/y mice.

Nature communications
2026

Molecular convergence enables precision medicine for pediatric low grade gliomas.

Discover oncology
2025

ASXL3 gene variants causing Bainbridge-Ropers syndrome: clinical and genetic analysis of four Chinese patients.

Frontiers in neuroscience
2026

Rapid Eye Movement (REM) Sleep Behaviour Disorder in Moebius Syndrome: A Rare Pediatric Case.

Cureus
2026

Neurological Consequences of Infantile Vitamin B12 Deficiency - A Prospective Cohort Study.

Pediatric neurology
2026

MSTO1-related mitochondrial myopathy and ataxia syndrome: Case series and literature review.

Neuromuscular disorders : NMD
2026

Analysis of Eya1 and Tbx1 mutants highlights interactions between the muscle and developing cartilage during external ear formation.

Development (Cambridge, England)
2026

Computed Tomography Analysis of Craniofacial Features in Japanese Patients With Cleidocranial Dysplasia.

Congenital anomalies
2025

[Analysis of variants of VPS13B gene in a child with Cohen syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

[Analysis of a child with You-Hoover-Fong syndrome due to compound heterozygous variants of the TELO2 gene and a literature review].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

[Clinical and genetic analysis of two children with Knobloch syndrome due to variants of COL18A1 gene].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

Flocoumafen exposure induces skeletal developmental toxicity and neurotoxicity in zebrafish (Danio rerio).

Toxicology letters
2026

Bi-allelic loss-of-function variants in JKAMP cause a neurodevelopmental syndrome associated with dysregulation of GPR37 trafficking.

American journal of human genetics
2026

Life expectancy of people with intellectual disability: a retrospective cohort study from New South Wales, Australia.

BMJ open
2026

Caregiver-reported social impacts in down syndrome regression disorder.

PloS one
2026

[Research progress in diagnosis and treatment of non-tumorous salivary gland diseases].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
2026

Loss of Zmiz1 in Mice Leads to Impaired Cortical Development and Autistic-Like Behaviors.

Biological psychiatry
2026

Melatonin protects against fluoride-induced developmental neurotoxicity by alleviating abnormal mitophagy and apoptosis via the PINK1/Parkin pathway.

Ecotoxicology and environmental safety
2026

A dual-reporter mouse for therapeutic discovery in Angelman syndrome.

JCI insight
2026

Muscle Thickness in Lower Extremity and Locomotor Functions in Children With Down Syndrome and Typical Developing Peers.

Journal of intellectual disability research : JIDR
2026

A Patient With Intellectual Disability, Agenesis of Corpus Callosum, and Congenital Heart Disease Associated With Chromosome 10p11.2 Microdeletion.

American journal of medical genetics. Part A
2026

A novel de Novo KCNC1 mutation (c.1147 C > T) presenting with epilepsy and ADHD: a case report and literature review.

BMC neurology
2026

[Research advance on the clinical phenotypes and molecular genetic mechanisms of Microcephalic primordial dwarfism].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

[Prenatal ultrasound manifestations and postnatal follow-up of fetuses with 22q11.2 microdeletion syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

[Clinical phenotypes and genetic analysis of five children with Lamb-Shaffer syndrome due to novel variants of SOX5 gene].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

Early rebalancing of neuroinflammatory cascades lastingly rescues prefrontal deficits in a 22q11.2ds model.

Brain, behavior, and immunity
2026

The impact of maternal flavivirus infections on fetal neurological outcomes: a scoping review.

Virology journal
2026

Progressive neuroinflammation and deficits in motor function in a mouse model with an Epg5 pathogenic variant of Vici syndrome.

Experimental & molecular medicine
2026

The genetic background of Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome: A systematic review.

Best practice & research. Clinical obstetrics & gynaecology
2026

EBF2 variant identified in a patient with atypical partial lipodystrophy causes adipose fibrosis and dysfunction.

The Journal of clinical investigation
2026

The 129S1/SvImJ Mouse Strain Is Resistant to the Effects of Early Embryonic Alcohol and Other Sonic Hedgehog Inhibitors.

Birth defects research
2026

Sagittal Craniosynostosis Associated With Chromosome 16p13.3 Duplication.

The Journal of craniofacial surgery
2026

Epigenetic Mechanisms of Reproductive Dysfunction Induced by Endocrine-Disrupting Chemicals: Evidence From Molecular Studies.

Frontiers in bioscience (Landmark edition)
2025

Population developmental hazard of over-the-counter NSAIDs.

Folia medica Cracoviensia
2026

Serum and cerebral folate are normal in Down Syndrome Regression Disorder.

Molecular autism
2026

Cognitive and neuropsychomotor development in craniosynostosis: an evaluation of the most affected functions.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2026

Neurodevelopmental outcomes in children with craniosynostosis: a retrospective cross-sectional analysis.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2026

Distinct thalamic functional connectivity and volume patterns across focal epilepsies in children: A multimodal neuroimaging study.

Epilepsia
2026

Expanding the Phenotype of STAMBP-Related Microcephaly-Capillary Malformation Syndrome.

American journal of medical genetics. Part A
2026

Atypical Histopathological Findings in an Epilepsy Surgery Case of Sturge-Weber Syndrome With Coexisting Developmental Venous Anomaly.

Neuropathology : official journal of the Japanese Society of Neuropathology
2025

Digital Technologies in Diagnosing Solitary Median Maxillary Central Incisor Syndrome.

Children (Basel, Switzerland)
2026

Interstitial 12p Deletion Syndrome: Revised Minimal Critical Region and Review of the Literature.

Genes
2026

Beyond Neurodevelopmental Delay: BICRA-Related Coffin-Siris Syndrome 12 with Severe Intestinal Dysmotility and Recurrent Pneumothorax.

Genes
2025

Genetic, Epigenetic, and Non-Genetic Factors in Testicular Dysgenesis Syndrome: A Narrative Review.

Genes
2025

A Systematic Review Illustrates the Expanding Clinical and Molecular Landscape of Helsmoortel-Van der Aa Syndrome.

Brain sciences
2026

Doppler Assessment of the Fetal Brain Circulation.

Diagnostics (Basel, Switzerland)
2026

Cohen syndrome with novel VPS13B variants presenting as early-onset diabetes: a case report.

Acta diabetologica
2025

Rodent models of genetic epilepsy and its association with neurocognitive impairment- a systematic review.

Frontiers in pharmacology
2026

Clinical and Molecular Characterization of Five Additional Individuals With SATB2-Associated Syndrome in Guangxi.

Biochemical genetics
2026

Clinical, Psychosocial, and Care Coordination Concerns in Macrocephaly Capillary Malformation Syndrome: Insights From a Large International Survey.

Pediatric blood & cancer
2026

A systematic review and meta-analysis of morphosyntactic skills in Williams syndrome.

Acta psychologica
2026

Association between cranial morphology and dysgnathias in adolescents and adults: A prospective case-control study.

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
2026

Transcription factor ZEB2 is essential for ureteral smooth muscle cell differentiation.

PLoS genetics
2026

Prenatal Diagnosis of Radio-Tartaglia Syndrome Caused by a Loss-of-Function Variant in SPEN in a Chinese Family.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
2025

A novel variant in SIAH1 associated with autosomal dominant Buratti-Harel syndrome.

Frontiers in neuroscience
2025

Microphthalmia and Infantile Spasms Leading to the Diagnosis of Aicardi Syndrome: A Case Report and Literature Review of a Rare Entity.

Cureus
2026

Mapping the Prenatal Growth of the Mandible.

The Journal of craniofacial surgery
2025

Malformation Pattern and Molecular Findings in the FGFR1-Related Hartsfield Syndrome Phenotype.

Medical sciences (Basel, Switzerland)
2026

Posterior Cranial Decompression in ERF-Mutated Multisuture Craniosynostosis.

The Journal of craniofacial surgery
2026

Novel variants in STAG2 and PKD1 associate with multiple congenital malformations and autosomal dominant polycystic kidney disease in a Chinese family: A case report and literature review.

Experimental and therapeutic medicine
2026

Clinical and genotypic characteristics of 19 children with STXBP1-encephalopathy.

Medicine
2026

Neonicotinoid-Induced Neurotoxicity in Developing Brain: A Systematic Review.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
2026

Long-term benefit of GPi-DBS in YY1-related dystonia: a case report.

Acta neurologica Belgica
2026

International Registry of NKX2-1-Related Disorders: Clinical, Genetic, and Imaging Perspectives.

Movement disorders : official journal of the Movement Disorder Society
2025

Multidisciplinary Approach to Comprehensive Dental Care in Sturge-Weber Syndrome: A Case Report.

International journal of clinical pediatric dentistry
2026

Brain volume trajectories in Down syndrome and autosomal dominant Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association
2026

Biomarker discovery in Lennox-Gastaut syndrome: Advances and challenges in electrophysiological, genetic, neuroimaging, and neuroinflammatory approaches.

Epilepsy & behavior : E&B
2026

Identification of novel variants in the ARID1B gene causing Coffin-Siris syndrome.

European journal of pediatrics
2026

Single-cell atlas of the developing Down syndrome brain cortex.

Nature medicine
2026

Loss of Drosophila UBE3A phenocopies Piezo dysfunction and drives hyperphagic feeding in Drosophila.

Fly
2026

AI-Based CT Image Recognition With Med-Gemini-3D in the Diagnosis of a Rare Craniofacial Condition: A Catlin Mark Skull.

The Journal of craniofacial surgery
2026

Clinical Factors Associated with Postnatal Urinary Titin N-Fragment in Neonates.

Clinical laboratory
2026

Caregiver-Reported Attainment of Developmental Skills in Down Syndrome.

Pediatrics
2026

Biallelic Rare COL18A1 Variants in Patients With Neurological Phenotypes Without Severe Ophthalmologic Abnormalities.

Pediatric neurology
2026

Altered hepatic metabolism in Down syndrome.

Cell reports
2025

[Nuclear Factor I-X Regulates Molecular Pathways Related to Craniofacial Development Through Phase Separation].

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
2026

Fertility preservation and counselling in prepubertal and pubertal girls with Turner syndrome.

Human reproduction (Oxford, England)
2026

Development of a patient-centered conceptual disease model in Ring 14 syndrome: a patient-centered model of lived experience.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
2026

Clinical and Genetic Analysis of SMARCC2-Related Diseases in Three Chinese Patients.

Molecular genetics & genomic medicine
2026

Descriptive Exploration of Features Among Infants With Prenatal Fentanyl Exposure in a Multisite Cohort of Maternal-Infant Dyads Affected by Opioid Use Disorder.

Journal of addiction medicine
2026

Etiology of Infantile Epileptic Spasms Syndrome and Clinical Response With Vigabatrin as the First Treatment.

Pediatric neurology
2026

Gallbladder Agenesis in a Patient With Klinefelter Syndrome Presenting With Hematemesis and Right Upper-Quadrant Pain.

The American journal of case reports
2026

Chromosome engineering to correct a complex rearrangement on Chromosome 8 reveals the effects of 8p syndrome on gene expression and neural differentiation.

Genome research
2026

The Italian Angelman Syndrome Registry (IReAS): a tool for standardized data collection and genotype-phenotype analysis.

European journal of medical genetics
2026

What Motivates Parents of Young Children With Down Syndrome to Participate in Research: A Focus Group Analysis.

Journal of applied research in intellectual disabilities : JARID
2026

Occipital Extracranial Dermoid Cyst in a Neonate With Cardiofaciocutaneous Syndrome Type 4 (CFC4): A Case Report.

Clinical case reports
2026

Proceedings of the 12th International Meeting on Neuroacanthocytosis, Cohen Syndrome, and Other VPS13-Related Disorders.

Tremor and other hyperkinetic movements (New York, N.Y.)
2026

The Sh3Pxd2bnee-/- mouse reveals developmental features of Frank-ter Haar syndrome.

Development (Cambridge, England)
2026

MicroRNAs in fetal alcohol spectrum disorders: A systematic review of prenatal exposure and molecular targets.

Reproductive toxicology (Elmsford, N.Y.)
2026

Mechanisms of D‑tetramethrin‑induced neurotoxicity and locomotor abnormalities in zebrafish embryos revealed by transcriptomic analysis.

Journal of hazardous materials
2025

Whole Exome Sequencing Uncovers Genetic Syndromes Associated with Orofacial Clefts presenting with Limb abnormalities in a Sub-Saharan African cohort.

Research square
2026

The missense mutation Y65C in PQBP1 causes microcephaly and cognitive deficits through a combination of partial loss-of-function and gain-of-function effects.

Nature communications
2026

Temporal transcriptomic changes during neurodevelopment in a mouse model of Smith-Lemli-Opitz syndrome.

The Journal of steroid biochemistry and molecular biology
2026

Explaining the Comprehension-Production Vocabulary Gap Through Neural Networks and Cross-Syndrome Evidence: Insights From Williams Syndrome.

Developmental science
2026

Elevated serotonin receptor 2A signaling restores learning and memory in a Fragile X syndrome model.

Scientific reports
2026

Alterations in electroencephalography signals in female fragile X syndrome mouse model on a C57BL/6J background.

Physiology & behavior
2026

Delayed diagnosis of Townes-Brocks syndrome accompanied with kidney failure.

CEN case reports
2026

Cornelia de Lange syndrome: What should a dermatologist know?

Advances in clinical and experimental medicine : official organ Wroclaw Medical University
2025

Heterozygous nonsense FLI1 p.Met100∗ variant results in thrombocytopenia and increased erythroid gene expression.

Research and practice in thrombosis and haemostasis
2026

Bilateral congenital glaucoma in a child with Nicolaides-Baraitser syndrome: a case report.

Annals of medicine and surgery (2012)
2026

Griscelli syndrome type 2: A rare case report of pediatric immunodeficiency and neurological implications.

Medicine
2026

Identification of a new frameshift homozygous variant of PEX3 gene in a preterm infant with profound global developmental delay and bilateral ptosis: a case report and updated literature review.

BMC pediatrics
2026

Review of early development in children with Down syndrome: family and clinician partnership.

BMJ paediatrics open
2025

Case Report: An exploration of the neurodevelopmental phenotype of five patients with 48,XXYY during early childhood years.

Frontiers in endocrinology
2026

Impact of consanguineous marriage on developmental dental anomalies: a cross-sectional study.

BMC oral health
2025

De novo MAP2K4 variants cause a novel neurodevelopmental syndrome with impaired JNK signaling in iPSC-derived neurons.

medRxiv : the preprint server for health sciences
2026

Clinical and Genetic Significance of Chromosomal Microarray Screening of Asymptomatic Newborns.

Journal of clinical laboratory analysis
2025

Expanding the clinicopathological spectrum of nevoid basal cell carcinoma syndrome associated with odontogenic keratocyst in the Indian population: an institutional experience of 39 cases and review of the literature.

International journal of oral and maxillofacial surgery
2026

Therapeutic GSK-3β targeting stabilizes multifunctional β-catenin to rescue neuronal and behavioral deficits in fragile X messenger ribonucleoprotein 1 knockout mice.

Brain research bulletin
2026

Cerebral Cavernous Malformations Presenting With Epileptic Spasms in Children.

Pediatric neurology
2025

Joint hypermobility as a manifestation of neonatal Sotos syndrome.

BMJ case reports
2026

Case report and literature review of neurodevelopmental syndrome linked to DOT1L variants.

Gene
2026

Results of dedicated venous nitinol stents in treating chronic inferior vena cava occlusions.

Journal of vascular surgery. Venous and lymphatic disorders
2026

Neuropsychiatric signatures across the Alzheimer's disease continuum in Down syndrome and sporadic forms: A biomarker-driven comparison.

Journal of Alzheimer's disease : JAD
2026

NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.

Neurology
2025

Expanding the Genetic Spectrum of Non-Syndromic Cleft Lip and Palate Through Whole-Exome Sequencing.

International journal of molecular sciences

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de perturbação do desenvolvimento-sobrecrescimento-dismorfia facial-perturbação comportamental.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de perturbação do desenvolvimento-sobrecrescimento-dismorfia facial-perturbação comportamental

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Tau pathology in epilepsy: emerging mechanisms and translational opportunities.
    Brain : a journal of neurology· 2026· PMID 41871415mais citado
  2. Novel PCDH12 pathogenic missense variants cause neurodevelopmental disorders with ocular malformation.
    medRxiv : the preprint server for health sciences· 2026· PMID 41867234mais citado
  3. Characterizing SCN1A -Related Disorders Using Real-World Data Across 681 Patient-Years.
    medRxiv : the preprint server for health sciences· 2026· PMID 41867217mais citado
  4. Recessive Loss of DIAPH1 Function Causes a Progressive Neurodevelopmental Syndrome with Variable Immunological Involvement.
    Genetics in medicine : official journal of the American College of Medical Genetics· 2026· PMID 41860019mais citado
  5. Disturbed mitochondrial maturation in cardiolipin remodeling-deficient cardiomyocytes.
    iScience· 2026· PMID 41847620mais citado
  6. Bi-allelic variants in FSD1L cause a neurodevelopmental disorder overlapping with L1 syndrome.
    Am J Hum Genet· 2026· PMID 41720098recente
  7. Bi-allelic PRMT9 loss-of-function variants cause a syndromic form of intellectual disability.
    Am J Hum Genet· 2025· PMID 41260215recente
  8. A rare variant of USP9X associated with female-restricted X-linked syndromic intellectual disability.
    Mol Biol Rep· 2025· PMID 41240171recente
  9. Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case.
    BMC Pediatr· 2025· PMID 41188742recente
  10. Whole-genome sequencing reveals individual and cohort level insights into chromosome 9p syndromes.
    Genome Med· 2025· PMID 41137173recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:652487(Orphanet)
  2. OMIM OMIM:620439(OMIM)
  3. MONDO:0957397(MONDO)
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome de perturbação do desenvolvimento-sobrecrescimento-dismorfia facial-perturbação comportamental
Compêndio · Raras BR

Síndrome de perturbação do desenvolvimento-sobrecrescimento-dismorfia facial-perturbação comportamental

ORPHA:652487 · MONDO:0957397
🇧🇷 Brasil SUS
Triagem
qPCR para deleção de SMN1 em sangue seco
PNTN
Fase 5
Incidência BR
1:10.000
Geral
CID-10
Q87.3 · Síndromes com malformações congênitas com hipercrescimento precoce
MedGen
UMLS
C5924786
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades